Biobanking prostate tissue

Background. Prostate cancer is the most common malignant disease in men. Obtaining high quality and diagnostically accurate tissue samples is paramount to the success of prostate cancer research. Collecting unfixed tissues from radical prostatectomy specimens for research purposes is challenging. Prostate cancer often cannot be detected on gross examination, and this tumor is known to be multifocal and heterogeneous making it of interest for interdisciplinary research.

Aim. To develop a protocol that will improve the accuracy and quantity of biobanked primary prostate cancer tissue.

Materials and methods. The removed unfixed prostate gland was dissected with a blade into two halves along the ureter, the tumor lesion was identified macroscopically, two sections were made: the first was separated into fragments and transferred into cryotubes and transport media for biobanking storage; the second was filled with gel, and frozen sectioning and histological verification of the tumor were performed.

Results. Tumor was detected in frozen sections in 78.95 % (30/38) of cases. The mean time from organ removal from the abdominal cavity to macroscopic evaluation was 8–10 minutes, and the total time for histological verification was 30 minutes. The quality control performed on the biobanked material confirms that the developed protocol guarantees that both tumors and normal tissues are represented for further studies.

Conclusion. This paper outlines a method for biobanking fresh prostate tissue removed during radical prostatectomy. The advantage of the method is the use of tissue samples both for diagnosis and for further study at the cellular and molecular levels.

1. Raychaudhuri R., Lin D.W., Montgomery R.B. Prostate cancer: a review. JAMA 2025;333(16):1433–46. DOI: 10.1001/jama.2025.0228

2. Bray F., Laversanne M., Sung H. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74(3):229–63. DOI: 10.3322/caac.21834

3. James N.D., Tannock I., N’Dow J. et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 2024;403(10437):1683–722. DOI: 10.1016/S0140-6736(24)00651-2

4. Malignant neoplasms in Russia in 2023 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2024. 276 p. (In Russ.).

5. Hall R., Bancroft E., Pashayan N. et al. Genetics of prostate cancer: a review of latest evidence. J Med Genet 2024;61(10):915–26. DOI: 10.1136/jmg-2024-109845

6. Titze U., Sommerkamp J., Stege C. et al. Ex vivo fluorescence confocal microscopy (FCM) ensures representative tissue in prostate cancer biobanking: a feasibility study. Int J Mol Sci 2022;23(20):12103. DOI: 10.3390/ijms232012103

7. Annaratone L., De Palma G., Bonizzi G. et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch 2021;479(2):233–46. DOI: 10.1007/s00428-021-03151-0

8. Castellani D., Perpepaj L., Fuligni D. et al. Advancements in artificial intelligence for robotic-assisted radical prostatectomy in men suffering from prostate cancer: results from a scoping review. Chin Clin Oncol 2024;13(4):54. DOI: 10.21037/cco-24-52

9. Ricciardelli C., Bianco-Miotto T., Jindal S. et al. Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies. Cancer Epidemiol Biomarkers Prev 2010;19(7):1755–65. DOI: 10.1158/1055-9965.EPI-10-0059

10. Schlomm T., Näkel E., Lübke A. et al. Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol 2008;53(2):333–46. DOI: 10.1016/j.eururo.2007.03.075

11. Dev H., Rickman D., Sooriakumaran P. et al. Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies. J Transl Med 2011;9:121. DOI: 10.1186/1479-5876-9-121

12. Berrino E., Annaratone L., Miglio U. et al. Cold formalin fixation guarantees DNA integrity in formalin fixed paraffin embedded tissues: premises for a better quality of diagnostic and experimental pathology with a specific impact on breast cancer. Front Oncol 2020;10:173. DOI: 10.3389/fonc.2020.00173

13. Bertilsson H., Angelsen A., Viset T. et al. RNA quality in fresh frozen prostate tissue from patients operated with radical prostatectomy. Scand J Clin Lab Invest 2010;70(1):45–53. DOI: 10.3109/00365510903540815

14. Müller A., Hovanec J., Josephs B. et al. A two-level biobank data protection concept for project-driven human sample collections. Biopreserv Biobank 2019;17(4):312–8. DOI: 10.1089/bio.2018.0112

15. Malsagova K., Kopylov A., Stepanov A. et al. Biobanks – a platform for scientific and biomedical research. Diagnostics 2020;10(7):485. DOI: 10.3390/diagnostics10070485

16. Bledsoe M.J. Ethical legal and social issues of biobanking: past, present, and future. Biopreserv Biobank 2017;15(2):142–7. DOI: 10.1089/bio.2017.0030

17. Sorokina A.G. Orlova Ya.A., Grigor’eva O.A. et al. Creation of a collection of different biological sample types from elderly patients to study the relationship of clinical, systemic, tissue and cellular biomarkers of accumulation of senescent cells during aging. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention 2021;20(8):3051. (In Russ.). DOI: 10.15829/1728-8800-2021-3051

18. Nosov D.A., Volkova M.I., Gladkov O.A. et al. Practical recommendations on drug treatment of prostate cancer. Zlokachestvennyye opuholi = Malignant tumors 2021;10(3s2-1): 556–72. DOI: 10.18027/2224-5057-2020-10-3s2-33

19. Kofanova O.A. Mommaerts K., Betsou F. Tube polypropylene: a neglected critical parameter for protein adsorption during biospecimen storage. Biopreserv Biobank 2015;13(4):296–8. DOI: 10.1089/bio.2014.0082

20. ISBER best practices: recommendations for repositories. 5th ed., 2023. Available at: https://www.ihmt.unl.pt/wp-content/uploads/2024/07/ISBER-Best-Practice-2023-5th-edition.pdf

21. GOST R ISO 20184-1-2021 In vitro molecular testing – Requirements for preanalytical processes in frozen tissue testing. Part 1: Isolated RNA. Available at: https://gostassistent.ru/doc/ fbf06485-b3f1-44fc-8142-6d546e2af0c0

22. GOST R ISO 20184-2-2021 In vitro molecular testing – Requirements for preanalytical processes in frozen tissues. Part 2: Isolated proteins. Available at: https://docs.cntd.ru/ document/1200181042

23. SPIDIA (Standardization and Improvement of Generic Pre-analytical Tools and Procedures for In Vitro Diagnostics) Available at: https://www.spidia.eu/projects/standard-documents

24. GOST R ISO 20387-2021 Biotechnology. Biobanking. General requirements. Available at: https://docs.cntd.ru/document/1200181384

25. Cai P.Y., Asad M., Augello M.A. et al. A multidisciplinary approach to optimize primary prostate cancer biobanking. Urol Oncol 2022;40(6):271.e1–7. DOI: 10.1016/j.urolonc.2022.03.015

26. Khabarov O.R., Seferov B.D., Aliev K.A. et al. Tumor tissue samples collection for scientific research in morphology and molecular oncology. Issledovaniya i praktika v meditsine = Research and Practical Medicine Journal 2024;11(1):29–39. (In Russ.). DOI: 10.17709/2410-1893-2024-11-1-3